Arkolith/Insider Trading/KNTE/Form 4

Foresite Capital Management IV, LLC

10% OwnerKinnate Biopharma Inc. (KNTE) · full profile →Form 4 · filed May 10, 2023
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2023Buy(P)1.6M$2.80$4.3M3.5M
May 8, 2023Buy(P)229K$2.80$641K521K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-028527) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML